As such, in a panel of 30 AML cases with a cytogenetically discernible chromosome 4 abnormality, seven patients (23%) had loss of function TET2 mutations, including 4 (13%) with monoallelic TET2 mutation (all of which were whole gene deletions resulting in reduced TET2 copy number). Here, TET2 is linked to acute myeloid leukemia.